Login / Signup

Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis.

Richard P RamonellImran Hasan Iftikhar
Published in: Lung (2020)
Benralizumab, dupilumab, mepolizumab, and reslizumab are all associated with decreased asthma exacerbations in patients with eosinophilic asthma, with no significant inter-drug differences.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • cystic fibrosis
  • allergic rhinitis
  • atopic dermatitis
  • bone marrow